Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland.
Helsinki Institute for Information Technology (HIIT), Aalto University, Finland.
Nucleic Acids Res. 2022 Jul 5;50(W1):W739-W743. doi: 10.1093/nar/gkac382.
SynergyFinder (https://synergyfinder.fimm.fi) is a free web-application for interactive analysis and visualization of multi-drug combination response data. Since its first release in 2017, SynergyFinder has become a popular tool for multi-dose combination data analytics, partly because the development of its functionality and graphical interface has been driven by a diverse user community, including both chemical biologists and computational scientists. Here, we describe the latest upgrade of this community-effort, SynergyFinder release 3.0, introducing a number of novel features that support interactive multi-sample analysis of combination synergy, a novel consensus synergy score that combines multiple synergy scoring models, and an improved outlier detection functionality that eliminates false positive results, along with many other post-analysis options such as weighting of synergy by drug concentrations and distinguishing between different modes of synergy (potency and efficacy). Based on user requests, several additional improvements were also implemented, including new data visualizations and export options for multi-drug combinations. With these improvements, SynergyFinder 3.0 supports robust identification of consistent combinatorial synergies for multi-drug combinatorial discovery and clinical translation.
SynergyFinder(https://synergyfinder.fimm.fi)是一款免费的网页应用程序,用于交互式分析和可视化多药物组合反应数据。自 2017 年首次发布以来,SynergyFinder 已成为多剂量组合数据分析的流行工具,部分原因是其功能和图形界面的开发得到了包括化学生物学家和计算科学家在内的多样化用户社区的推动。在这里,我们描述了这个社区努力的最新升级版本,SynergyFinder 3.0 版,引入了一些新的功能,支持组合协同作用的交互式多样本分析,一种新的共识协同作用评分,结合了多个协同作用评分模型,以及改进的异常值检测功能,消除了假阳性结果,以及许多其他后分析选项,如药物浓度加权和区分协同作用的不同模式(效力和疗效)。根据用户的要求,还实现了其他一些改进,包括多药物组合的新数据可视化和导出选项。通过这些改进,SynergyFinder 3.0 支持对多药物组合发现和临床转化的一致组合协同作用进行稳健识别。